Metastasis in patients with hepatocellular carcinoma: Prevalence, determinants, prognostic impact and ability to improve the Barcelona Clinic Liver Cancer system-Reference-Cited by-同舟云学术

Metastasis in patients with hepatocellular carcinoma: Prevalence, determinants, prognostic impact and ability to improve the Barcelona Clinic Liver Cancer system

Published:2018-04-24 Issue:10 Volume:38 Page:1803-1811
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Hsu Chia-Yang¹²³,Liu Po-Hong¹²⁴,Ho Shu-Yein¹²,Huang Yi-Hsiang¹⁵^ORCID,Lee Yun-Hsuan¹²,Lee Rheun-Chuan²⁶,Nagaria Teddy S.⁷,Hou Ming-Chih¹²,Huo Teh-Ia¹²⁸^ORCID

Affiliation:

1. Department of Medicine; Taipei Veterans General Hospital; Taipei Taiwan

2. Faculty of Medicine; National Yang-Ming University School of Medicine; Taipei Taiwan

3. Department of Internal Medicine; University of Nevada School of Medicine; Reno NV USA

4. Harvard T.H. Chan School of Public Health; Boston MA USA

5. Institute of Clinical Medicine; National Yang-Ming University School of Medicine; Taipei Taiwan

6. Department of Radiology; Taipei Veterans General Hospital; Taipei Taiwan

7. Department of Laboratory Medicine and Pathobiology; University of Toronto; Toronto ON Canada

8. Institute of Pharmacology; National Yang-Ming University School of Medicine; Taipei Taiwan

Funder

Center of Excellence for Cancer Research at Taipei Veterans General Hospital

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13748/fullpdf

Reference30 articles.

1. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

2. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;European Association for Study of Liver, European Organisation for Research and Treatment of Cancer;Eur J Cancer,2012

3. Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: a nomogram study;Hsu;PLoS One,2017

4. Extrahepatic metastases of hepatocellular carcinoma;Katyal;Radiology,2000

5. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma;Uka;World J Gastroenterol,2007

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival Benefit of Synchronous Lenvatinib Combined PD-1 Inhibitors for Advanced Hepatocellular Carcinoma Beyond Oligometastasis;ImmunoTargets and Therapy;2024-06

2. A New Nomogram for Predicting Extrahepatic Metastases in Patients With Hepatocellular Carcinoma： A population-based study of the SEER database and a Chinese single-institutional cohort;2024-01-05

3. Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma;Cancer Cell;2024-01

4. Pretreatment Non-Invasive Biomarkers as Predictors to Estimate Portal Vein Tumor Thrombosis (PVTT) Risk and Long-Term Survival in HBV-Related Hepatocellular Carcinoma Patients Without PVTT;Journal of Hepatocellular Carcinoma;2023-12

5. Effectiveness of lenvatinib plus immune checkpoint inhibitors in primary advanced hepatocellular carcinoma beyond oligometastasis;Clinical and Translational Medicine;2023-02-28